ReviewCells2020

Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease.

Anne Fougerat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.